Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in Oncogene

Retrieve available abstracts of 40 articles:
HTML format

Single Articles

    April 2024
  1. SAFFERTHAL C, Rohde K, Fulda S
    Correction: Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells.
    Oncogene. 2024 Apr 29. doi: 10.1038/s41388-024-03022.

    March 2024
  2. GUO T, Wang Y, Sun X, Hou S, et al
    Loss of RNA-binding protein CELF2 promotes acute leukemia development via FAT10-mTORC1.
    Oncogene. 2024 Mar 21. doi: 10.1038/s41388-024-03006.
    PubMed     Abstract available

    December 2023
  3. LEI H, Xu H, Yang L, Wang Y, et al
    USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia.
    Oncogene. 2023 Dec 16. doi: 10.1038/s41388-023-02921.

  4. NOURA M, Matsuo H, Yasuda T, Tsuzuki S, et al
    Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia.
    Oncogene. 2023 Dec 15. doi: 10.1038/s41388-023-02913.
    PubMed     Abstract available

  5. DI MAMBRO A, Arroyo-Berdugo Y, Fioretti T, Randles M, et al
    SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML.
    Oncogene. 2023;42:3670-3683.
    PubMed     Abstract available

    November 2023
  6. ERKNER E, Hentrich T, Schairer R, Fitzel R, et al
    The ROR?/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia.
    Oncogene. 2023 Nov 29. doi: 10.1038/s41388-023-02903.
    PubMed     Abstract available

    October 2023
  7. XIE X, Zhang W, Zhou X, Xu B, et al
    Low doses of IFN-gamma maintain self-renewal of leukemia stem cells in acute myeloid leukemia.
    Oncogene. 2023 Oct 23. doi: 10.1038/s41388-023-02874.
    PubMed     Abstract available

    September 2023
  8. MA H, Cui J, Liu Z, Fang W, et al
    Blockade of de novo pyrimidine biosynthesis triggers autophagic degradation of oncoprotein FLT3-ITD in acute myeloid leukemia.
    Oncogene. 2023 Sep 26. doi: 10.1038/s41388-023-02848.
    PubMed     Abstract available

  9. PAWLIKOWSKA P, Delestre L, Gregoricchio S, Oppezzo A, et al
    FANCA deficiency promotes leukaemic progression by allowing the emergence of cells carrying oncogenic driver mutations.
    Oncogene. 2023;42:2764-2775.
    PubMed     Abstract available

    July 2023
  10. QI Y, Hu M, Han C, Wang J, et al
    ARHGAP4 promotes leukemogenesis in acute myeloid leukemia by inhibiting DRAM1 signaling.
    Oncogene. 2023 Jul 13. doi: 10.1038/s41388-023-02770.
    PubMed     Abstract available

    March 2023
  11. WANG D, Zheng L, Cheng BYL, Sin CF, et al
    Correction: Transgenic IDH2(R172K) and IDH2(R140Q) zebrafish models recapitulated features of human acute myeloid leukemia.
    Oncogene. 2023 Mar 15. doi: 10.1038/s41388-023-02664.

  12. AN N, Khan S, Imgruet MK, Jueng L, et al
    Oncogenic RAS promotes leukemic transformation of CUX1-deficient cells.
    Oncogene. 2023;42:881-893.
    PubMed     Abstract available

    February 2023
  13. WANG D, Zheng L, Cheng BYL, Sin CF, et al
    Transgenic IDH2(R172K) and IDH2(R140Q) zebrafish models recapitulated features of human acute myeloid leukemia.
    Oncogene. 2023 Feb 4. doi: 10.1038/s41388-023-02611.
    PubMed     Abstract available

    December 2022
  14. GIANNI M, Terao M, Kurosaki M, Paroni G, et al
    Correction: S100A3 a partner protein regulating the stability/activity of RARalpha and PML-RARalpha in cellular models of breast/lung cancer and acute myeloid leukemia.
    Oncogene. 2022 Dec 7. doi: 10.1038/s41388-022-02564.

    November 2022
  15. MA D, Liu P, Hu C, Zhou Z, et al
    Intracellular angiopoietin-1 promotes TKI-resistance via activation of JAK/STAT5 pathway in chronic myeloid leukemia.
    Oncogene. 2022 Nov 17. pii: 10.1038/s41388-022-02536.
    PubMed     Abstract available

  16. BURKE A, Borot F, Du X, Churchill M, et al
    A novel therapeutic bispecific format based on synthetic orthogonal heterodimers enables T cell activity against Acute myeloid leukemia.
    Oncogene. 2022 Nov 10. pii: 10.1038/s41388-022-02532.
    PubMed     Abstract available

  17. LEE LM, Christodoulou EG, Shyamsunder P, Chen BJ, et al
    A novel network pharmacology approach for leukaemia differentiation therapy using Mogrify((R)).
    Oncogene. 2022;41:5160-5175.
    PubMed     Abstract available

    October 2022
  18. KANG S, Wang L, Xu L, Wang R, et al
    Decitabine enhances targeting of AML cells by NY-ESO-1-specific TCR-T cells and promotes the maintenance of effector function and the memory phenotype.
    Oncogene. 2022;41:4696-4708.
    PubMed     Abstract available

    September 2022
  19. MAIQUES-DIAZ A, Nicosia L, Basma NJ, Romero-Camarero I, et al
    HMG20B stabilizes association of LSD1 with GFI1 on chromatin to confer transcription repression and leukemia cell differentiation block.
    Oncogene. 2022 Sep 28. pii: 10.1038/s41388-022-02471.
    PubMed     Abstract available

    May 2022
  20. GARZON R, Pichiorri F, Palumbo T, Visentini M, et al
    Correction to: MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia.
    Oncogene. 2022 May 11. pii: 10.1038/s41388-022-02351.

    March 2022
  21. WANG H, Zhang D, Cui X, Dai Y, et al
    Loss of IRF7 accelerates acute myeloid leukemia progression and induces VCAM1-VLA-4 mediated intracerebral invasion.
    Oncogene. 2022 Mar 7. pii: 10.1038/s41388-022-02233.
    PubMed     Abstract available

  22. CHEN TC, Yao CY, Chen YR, Yuan CT, et al
    Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair.
    Oncogene. 2022;41:1576-1588.
    PubMed     Abstract available

    January 2022
  23. FIDYT K, Pastorczak A, Cyran J, Crump NT, et al
    Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax.
    Oncogene. 2022 Jan 28. pii: 10.1038/s41388-022-02196.
    PubMed     Abstract available

  24. MADRAZO E, Gonzalez-Novo R, Ortiz-Placin C, Garcia de Lacoba M, et al
    Fast H3K9 methylation promoted by CXCL12 contributes to nuclear changes and invasiveness of T-acute lymphoblastic leukemia cells.
    Oncogene. 2022 Jan 8. pii: 10.1038/s41388-021-02168.
    PubMed     Abstract available

    December 2021
  25. PAGE EC, Heatley SL, Eadie LN, McClure BJ, et al
    HMGN1 plays a significant role in CRLF2 driven Down Syndrome leukemia and provides a potential therapeutic target in this high-risk cohort.
    Oncogene. 2021 Dec 2. pii: 10.1038/s41388-021-02126.
    PubMed     Abstract available

    October 2021
  26. ZHANG J, Zhai J, Wong CC, Chen H, et al
    A novel amplification gene PCI domain containing 2 (PCID2) promotes colorectal cancer through directly degrading a tumor suppressor promyelocytic leukemia (PML).
    Oncogene. 2021 Oct 8. pii: 10.1038/s41388-021-01941.
    PubMed     Abstract available

    September 2021
  27. HELTEMES-HARRIS LM, Hubbard GK, LaRue RS, Munro SA, et al
    Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia.
    Oncogene. 2021 Sep 17. pii: 10.1038/s41388-021-02012.
    PubMed     Abstract available

  28. WILHELM A, Marschalek R
    The role of reciprocal fusions in MLL-r acute leukemia: studying the chromosomal translocation t(4;11).
    Oncogene. 2021 Sep 6. pii: 10.1038/s41388-021-02001.
    PubMed     Abstract available

  29. REJESKI K, Duque-Afonso J, Lubbert M
    AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms.
    Oncogene. 2021;40:5665-5676.
    PubMed     Abstract available

    August 2021
  30. KUNDU A, Kowarz E, Marschalek R
    The role of reciprocal fusions in MLL-r acute leukemia: studying the chromosomal translocation t(6;11).
    Oncogene. 2021 Aug 5. pii: 10.1038/s41388-021-01983.
    PubMed     Abstract available

  31. SCHWALBE EC, H L, Lafta F, Barrow TM, et al
    Integration of genome-level data to allow identification of subtype-specific vulnerability genes as novel therapeutic targets.
    Oncogene. 2021;40:5213-5223.
    PubMed     Abstract available

    July 2021
  32. KARUNANITHI S, Liu R, Hou Y, Gonzalez G, et al
    Thioredoxin reductase is a major regulator of metabolism in leukemia cells.
    Oncogene. 2021 Jul 8. pii: 10.1038/s41388-021-01924.
    PubMed     Abstract available

    June 2021
  33. CHEN Z, Shao YL, Wang LL, Lin J, et al
    YTHDF2 is a potential target of AML1/ETO-HIF1alpha loop-mediated cell proliferation in t(8;21) AML.
    Oncogene. 2021;40:3786-3798.
    PubMed     Abstract available

    May 2021
  34. YUSENKO MV, Trentmann A, Casolari DA, Abdel Ghani L, et al
    C/EBPbeta is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia.
    Oncogene. 2021 May 6. pii: 10.1038/s41388-021-01800.
    PubMed     Abstract available

    April 2021
  35. ZHOU M, Zhang X, Liu C, Nie D, et al
    Targeting protein lysine methyltransferase G9A impairs self-renewal of chronic myelogenous leukemia stem cells via upregulation of SOX6.
    Oncogene. 2021 Apr 30. pii: 10.1038/s41388-021-01799.
    PubMed     Abstract available

  36. WEI Y, Lu W, Yu Y, Zhai Y, et al
    miR-29c&b2 encourage extramedullary infiltration resulting in the poor prognosis of acute myeloid leukemia.
    Oncogene. 2021 Apr 22. pii: 10.1038/s41388-021-01775.
    PubMed     Abstract available

  37. HAO T, Zhang C, Wang Z, Buck A, et al
    An aging mouse model of human chronic myeloid leukemia.
    Oncogene. 2021 Apr 6. pii: 10.1038/s41388-021-01770.
    PubMed     Abstract available

  38. BENCOMO-ALVAREZ AE, Rubio AJ, Olivas IM, Gonzalez MA, et al
    Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B.
    Oncogene. 2021;40:2697-2710.
    PubMed     Abstract available

    January 2021
  39. BAI J, Yokomizo-Nakano T, Kubota S, Sun Y, et al
    Overexpression of Hmga2 activates Igf2bp2 and remodels transcriptional program of Tet2-deficient stem cells in myeloid transformation.
    Oncogene. 2021 Jan 15. pii: 10.1038/s41388-020-01629.
    PubMed     Abstract available

    November 2020
  40. SARI IN, Yang YG, Wijaya YT, Jun N, et al
    AMD1 is required for the maintenance of leukemic stem cells and promotes chronic myeloid leukemic growth.
    Oncogene. 2020 Nov 17. pii: 10.1038/s41388-020-01547.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.